Insulin detemir versus glyburide in women with gestational diabetes mellitus

References

• Metzger BE, Lowe LP, Dyer AR, et al. Group HSCR. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002
   PubMed Web of Science ®Google Scholar
• Jensen DM, Damm P, Sorensen B, et al. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 2001;185:413–19
   PubMed Web of Science ®Google Scholar
• Jensen DM, Korsholm L, Ovesen P, et al. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 2008;87:59–62
   PubMed Web of Science ®Google Scholar
• Ferrara A, Weiss NS, Hedderson MM, et al. Pregnancy plasma glucose levels exceeding the American diabetes association thresholds, but below the national diabetes data group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 2007;50:298–306
   PubMed Web of Science ®Google Scholar
• Sermer M, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto tri-hospital gestational diabetes project. Am J Obstet Gynecol 1995;173:146–56
   PubMed Web of Science ®Google Scholar
• Hartling L, Dryden DM, Guthrie A, et al. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. preventive services task force and the national institutes of health office of medical applications of research. Ann Intern Med 2013;159:123–9
   PubMed Web of Science ®Google Scholar
• Langer O, Yogev Y, Xenakis EM, Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol 2005;192:134–9
   PubMed Web of Science ®Google Scholar
• Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134–8
   PubMed Web of Science ®Google Scholar
• Balsells M, Garcia-Patterson A, Sola I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 2015;350:h102
   PubMed Web of Science ®Google Scholar
• American Diabetes A. Management of diabetes in pregnancy. Diabetes Care 2015;38:S77–9
   PubMedGoogle Scholar
• Hod M, Mathiesen ER, Jovanovic L, et al. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes. J Matern Fetal Neonatal Med 2014;27:7–13
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Hod M, Ivanisevic M, et al. Detemir in Pregnancy Study G. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 2012;35:2012–7
   PubMed Web of Science ®Google Scholar
• Mello G, Biagioni S, Ottanelli S, et al. Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women. J Matern Fetal Neonatal Med 2015;28:276–80
   PubMed Web of Science ®Google Scholar
• Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013;98:4227–49
   PubMed Web of Science ®Google Scholar
• Camelo Castillo W, Boggess K, Sturmer T, et al. Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol 2014;123:1177–84
   PubMed Web of Science ®Google Scholar
• Zeng YC, Li MJ, Chen Y, et al. The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis. Adv Med Sci 2014;59:95–101
   PubMed Web of Science ®Google Scholar
• Poolsup N, Suksomboon N, Amin M. Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis. PLoS One 2014;9:e109985
   PubMed Web of Science ®Google Scholar
• Dollberg S, Haklai Z, Mimouni FB, et al. Birth weight standards in the live-born population in Israel. Isr Med Assoc J 2005;7:311–14
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard U, Kristensen PL, Beck-Nielsen H, et al. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial. Lancet Diabetes Endocrinol 2014;2:553–61
   PubMed Web of Science ®Google Scholar
• Haukka J, Hoti F, Erasto P, et al. Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study. Pharmacoepidemiol Drug Saf 2013;22:1326–35
   PubMed Web of Science ®Google Scholar
• Heinemann L, Sinha K, Weyer C, et al. Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304. Diabet Med 1999;16:332–8
   PubMed Web of Science ®Google Scholar
• Kalra S, Mukherjee JJ, Venkataraman S, et al. Hypoglycemia: The neglected complication. Indian J Endocrinol Metab 2013;17:819–34
   PubMedGoogle Scholar
• Yogev Y, Ben-Haroush A, Chen R, et al. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 2004;104:88–93
   PubMed Web of Science ®Google Scholar
• Jacobson GF, Ramos GA, Ching JY, et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005;193:118–24
   PubMed Web of Science ®Google Scholar
• Haak T, Tiengo A, Draeger E, et al. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes. Diabetes Obes Metab 2005;7:56–64
   PubMed Web of Science ®Google Scholar
• Yale JF, Damci T, Kaiser M, et al. Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study. Diabetol Metab Syndr 2013;5:56
   PubMed Web of Science ®Google Scholar
• Petrie JR, Adler A, Vella S. What to add in with metformin in type 2 diabetes? QJM 2011;104:185–92
   PubMed Web of Science ®Google Scholar
• Buschur E, Brown F, Wyckoff J. Using oral agents to manage gestational diabetes: what have we learned? Curr Diab Rep 2015;15:570
   PubMed Web of Science ®Google Scholar
• Carroll DG, Kelley KW. Review of metformin and glyburide in the management of gestational diabetes. Pharm Pract (Granada) 2014;12:528
   PubMedGoogle Scholar
• Camelo Castillo W, Boggess K, Sturmer T, et al. Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes. JAMA Pediatr 2015;169:452–8
   PubMed Web of Science ®Google Scholar